TIL Instil Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TIL

Price (delayed)

$11.3

Market cap

$73.49M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$24

Enterprise value

$147.1M

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.

Highlights
Instil Bio's quick ratio has surged by 81% YoY and by 6% QoQ
TIL's net income is up by 30% YoY and by 21% QoQ
The company's equity fell by 38% YoY and by 3.5% QoQ
Instil Bio's debt has increased by 9% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://instilbio.com
Peers: OMER OMGA

Key stats

What are the main financial stats of TIL
Market
Shares outstanding
6.5M
Market cap
$73.49M
Enterprise value
$147.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.33
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$150.88M
EBITDA
-$145.48M
Free cash flow
-$102.69M
Per share
EPS
-$24
Free cash flow per share
-$15.79
Book value per share
$34.72
Revenue per share
$0
TBVPS
$50.07
Balance sheet
Total assets
$325.63M
Total liabilities
$99.8M
Debt
$84.3M
Equity
$225.83M
Working capital
$150.2M
Liquidity
Debt to equity
0.37
Current ratio
15.22
Quick ratio
14.38
Net debt/EBITDA
-0.51
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-41.6%
Return on equity
-58.5%
Return on invested capital
-35.5%
Return on capital employed
-47.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TIL stock price

How has the Instil Bio stock price performed over time
Intraday
2.91%
1 week
4.34%
1 month
2.54%
1 year
-12.32%
YTD
48.29%
QTD
4.63%

Financial performance

How have Instil Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$159.17M
Net income
-$156.09M
Gross margin
N/A
Net margin
N/A
TIL's net income is up by 30% YoY and by 21% QoQ
The operating income has grown by 30% YoY and by 22% from the previous quarter

Growth

What is Instil Bio's growth rate over time

Valuation

What is Instil Bio stock price valuation
P/E
N/A
P/B
0.33
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TIL's EPS is up by 30% year-on-year and by 21% since the previous quarter
TIL's price to book (P/B) is 65% higher than its last 4 quarters average of 0.2
The company's equity fell by 38% YoY and by 3.5% QoQ

Efficiency

How efficient is Instil Bio business performance
TIL's ROIC is up by 22% year-on-year and by 18% since the previous quarter
The return on equity has declined by 14% year-on-year but it rose by 11% since the previous quarter
Instil Bio's return on assets has increased by 12% QoQ

Dividends

What is TIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TIL.

Financial health

How did Instil Bio financials performed over time
Instil Bio's current ratio has surged by 85% YoY and by 4.7% QoQ
Instil Bio's quick ratio has surged by 81% YoY and by 6% QoQ
Instil Bio's debt is 63% less than its equity
The debt to equity has soared by 76% YoY and by 2.8% from the previous quarter
The company's equity fell by 38% YoY and by 3.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.